Retraction notice to ”Seleno-cyclodextrin sensitizes human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression” [Eur J Cancer., 47 (2011) 1890-1907, http://dx.doi.org/10.1016/j.ejca.2011.04.004, (S095980491100253X), (10.1016/j.ejca.2011.04.004)];Seleno-cyclodextrin sensitises human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression

European Journal of Cancer

Volumn 47, Issue 12, 2011, Pages 1890-1907

  Lin, Tingting ^a,b   Ding, Zhiying ^b   Li, Nan ^a   Xu, Jiayun ^a   Luo, Guimin ^b   Liu, Junqiu ^a   Shen, Jiacong ^a  

^a Jilin University   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Apoptosis; Death receptor; Nuclear factor B; Seleno cyclodextrin; TRAIL

Indexed keywords

2 SELENIUM BRIDGED BETA CYCLODEXTRIN; ANTINEOPLASTIC AGENT; CASPASE; DEATH RECEPTOR 5; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; ORGANOSELENIUM DERIVATIVE; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL; CANCER INHIBITION; CANCER RESISTANCE; CANCER TISSUE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL NUCLEUS; CELL VIABILITY; CONTROLLED STUDY; CYTOSOL; DOSE RESPONSE; DOWN REGULATION; DRUG TOLERABILITY; ENZYME ACTIVITY; EPITHELIUM CELL; FEMALE; GENE TRANSLOCATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR XENOGRAFT; UPREGULATION;

EID: 80051522609     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2023.04.015     Document Type: Erratum

References (53)

1. H. Walczak, R.E. Miller, and K. Ariail Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo Nat Med 5 1999 157 163 (Pubitemid 29068521)
2. G. Pan, K. O'Rourke, and A.M. Chinnaiyan The receptor for the cytotoxic ligand TRAIL Science 276 1997 111 113 (Pubitemid 27161256)
3. H. Walczak, M.A. Degli-Esposti, and R.S. Johnson TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL EMBO J 16 1997 5386 5397 (Pubitemid 27380146)
4. M.A. Degli-Esposti, P.J. Smolak, and H. Walczak Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family J Exp Med 186 1997 1165 1170 (Pubitemid 27441160)
5. M.A. Degli-Esposti, W.C. Dougall, and P.J. Smolak The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain Immunity 7 1997 813 820 (Pubitemid 28064894)
6. J.G. Emery, P. McDonnell, and M.B. Burke Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL J Biol Chem 273 1998 14363 14367 (Pubitemid 28319153)
7. F.C. Kischkel, S. Hellbardt, and I. Behrmann Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor EMBO J 14 1995 5579 5588
8. F.C. Kischkel, D.A. Lawrence, and A. Chuntharapai Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5 Immunity 12 2000 611 620
9. K.M. Boatright, M. Renatus, and F.L. Scott A unified model for apical caspase activation Mol Cell 11 2003 529 541 (Pubitemid 36293843)
10. P. Schneider, M. Thome, and K. Burns TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB Immunity 7 1997 831 836 (Pubitemid 28064896)
11. Y.S. Kim, R.F. Schwabe, T. Qian, J.J. Lemasters, and D.A. Brenner TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells Hepatology 36 2002 1498 1508 (Pubitemid 35403540)
12. S. Kreuz, D. Siegmund, P. Scheurich, and H. Wajant NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling Mol Cell Biol 21 2001 3964 3973 (Pubitemid 32476458)
13. C.Y. Wang, M.W. Mayo, R.G. Korneluk, D.V. Goeddel, and A.S. Baldwin Jr NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation Science 281 1998 1680 1683
14. M. Rahman, J.G. Pumphrey, and S. Lipkowitz The TRAIL to targeted therapy of breast cancer Adv Cancer Res 103 2009 43 73
15. M.M. Keane, S.A. Ettenberg, M.M. Nau, E.K. Russell, and S. Lipkowitz Chemotherapy augments TRAIL-induced apoptosis in breast cell lines Cancer Res 59 1999 734 741 (Pubitemid 29076075)
16. T.R. Singh, S. Shankar, X. Chen, M. Asim, and R.K. Srivastava Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo Cancer Res 63 2003 5390 5400 (Pubitemid 37139856)
17. T.M. Ganten, R. Koschny, and J. Sykora Preclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either alone or in combination with chemotherapeutic drugs Clin Cancer Res 12 2006 2640 2646
18. R. Koschny, T.M. Ganten, and J. Sykora TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specific apoptosis within a therapeutic window Hepatology 45 2007 649 658 (Pubitemid 46450616)
19. X. Ren, L. Yang, and J. Liu A novel glutathione peroxidase mimic with antioxidant activity Arch Biochem Biophys 387 2004 250 256
20. Z.D. Jia, Y. Mu, G.L. Yan, and G.M. Luo Comparison between the effects of 2-selenium-bridged beta-cyclodextrin and ebselen on treating SHRsp stroke Chem Res Chin U 24 2008 1 8
21. H. Sies Ebselen, a selenoorganic compound as glutathione peroxidase mimic Free Radic Biol Med 14 1993 313 323 (Pubitemid 23066372)
22. J. Liu, G. Luo, and X. Ren A bis-cyclodextrin diselenide with glutathione peroxidase-like activity Biochim Biophys Acta 1481 2000 222 228
23. Z. Dong, J. Liu, and S. Mao Aryl thiol substrate 3-carboxy-4- nitrobenzenethiol strongly stimulating thiol peroxidase activity of glutathione peroxidase mimic 2,2′-ditellurobis(2-deoxy-beta-cyclodextrin) J Am Chem Soc 126 2004 16395 16404 (Pubitemid 40081937)
24. Y. Sun, Y. Mu, and S. Ma The molecular mechanism of protecting cells against oxidative stress by 2-selenium-bridged beta-cyclodextrin with glutathione peroxidase activity Biochim Biophys Acta 1743 2005 199 204 (Pubitemid 40552802)
25. M. McNaughton, L. Engman, A. Birmingham, G. Powis, and I.A. Cotgreave Cyclodextrin-derived diorganyl tellurides as glutathione peroxidase mimics and inhibitors of thioredoxin reductase and cancer cell growth J Med Chem 47 2004 233 239 (Pubitemid 38040507)
26. L. Engman, I. Cotgreave, and M. Angulo Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents Anticancer Res 17 1997 4599 4605 (Pubitemid 28081751)
27. T. Maraldi, C. Prata, and D. Fiorentini Induction of apoptosis in a human leukemic cell line via reactive oxygen species modulation by antioxidants Free Radic Biol Med 46 2009 244 252
28. V. Sharma, R. Tewari, U.H. Sk, C. Joseph, and E. Sen Ebselen sensitizes glioblastoma cells to Tumor Necrosis Factor (TNFalpha)-induced apoptosis through two distinct pathways involving NF-kappaB downregulation and Fas-mediated formation of death inducing signaling complex Int J Cancer 123 2008 2204 2212
29. G. Powis, J.R. Gasdaska, and P.Y. Gasdaska Selenium and the thioredoxin redox system: effects on cell growth and death Oncol Res 9 1997 303 312 (Pubitemid 127825984)
30. S. Urig, and K. Becker On the potential of thioredoxin reductase inhibitors for cancer therapy Semin Cancer Biol 16 2006 452 465 (Pubitemid 44780136)
31. J.D. Pennington, K.M. Jacobs, and L. Sun Thioredoxin and thioredoxin reductase as redox-sensitive molecular targets for cancer therapy Curr Pharm Des 13 2007 3368 3377 (Pubitemid 350201671)
32. K. Wang, P. Gong, and L. Liu Effect of 2-TeCD on the expression of adhesion molecules in human umbilical vein endothelial cells under the stimulation of tumor necrosis factor-alpha Int Immunopharmacol 9 2009 1087 1091
33. T.C. Chou, and P. Talalay Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv Enzyme Regul 22 1984 27 55
34. H.L. Ford, and A.B. Pardee Cancer and the cell cycle J Cell Biochem 32-33 1999 166 172 (Pubitemid 30041823)
35. V. Venkateswaran, L.H. Klotz, and N.E. Fleshner Selenium modulation of cell proliferation and cell cycle biomarkers in human prostate carcinoma cell lines Cancer Res 62 2002 2540 2545 (Pubitemid 34462732)
36. 2-M arrest, and apoptosis Clin Cancer Res 8 2002 3512 3519
37. M.M. Keane, Y. Rubinstein, and M. Cuello Inhibition of NF-kappaB activity enhances TRAIL mediated apoptosis in breast cancer cell lines Breast Cancer Res Treat 64 2000 211 219 (Pubitemid 32010339)
38. S. Ghosh, and D. Baltimore Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B Nature 344 1990 678 682
39. A.A. Beg, S.M. Ruben, and R.I. Scheinman I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention Genes Dev 6 1992 1899 1913
40. S.V. Madhunapantula, D. Desai, and A. Sharma PBISe, a novel selenium-containing drug for the treatment of malignant melanoma Mol Cancer Ther 7 2008 1297 1308
41. M. Oya, M. Ohtsubo, and A. Takayanagi Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells Oncogene 20 2001 3888 3896 (Pubitemid 32646199)
42. S. Khanbolooki, S.T. Nawrocki, and T. Arumugam Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells Mol Cancer Ther 5 2006 2251 2260 (Pubitemid 44530462)
43. K. Yamaguchi, R.G. Uzzo, and J. Pimkina Methylseleninic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis Oncogene 24 2005 5868 5877 (Pubitemid 43080078)
44. H. Hu, C. Jiang, and T. Schuster Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathway Mol Cancer Ther 5 2006 1873 1882 (Pubitemid 44323256)
45. S. Li, T. Yan, J.Q. Yang, T.D. Oberley, and L.W. Oberley The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase Cancer Res 60 2000 3927 3939 (Pubitemid 32204589)
46. S.S. Brar, T.P. Kennedy, and A.R. Whorton Reactive oxygen species from NAD(P)H:quinone oxidoreductase constitutively activate NF-kappaB in malignant melanoma cells Am J Physiol Cell Physiol 280 2001 C659 C676
47. C. Kretz-Remy, P. Mehlen, M.E. Mirault, and A.P. Arrigo Inhibition of IkB - a phosphorylation and degradation and subsequent NF-kB activation by glutathione peroxidase overexpression J Cell Biol 133 1996 1083 1093
48. J. Wenk, J. Schüller, and C. Hinrichs Overexpression of phospholipid-hydroperoxide glutathione peroxidase in human dermal fibroblasts abrogates UVA irradiation-induced expression of interstitial collagenase/matrix metalloproteinase-1 by suppression of phosphatidylcholine hydroperoxide-mediated NFkappaB activation and interleukin-6 release J Biol Chem 279 2004 45634 45642 (Pubitemid 39491551)
49. Q. Li, S. Sanlioglu, and S. Li GPx-1 gene delivery modulates NFkappaB activation following diverse environmental injuries through a specific subunit of the IKK complex Antioxid Redox Signal 3 2001 415 432 (Pubitemid 32646033)
50. K.C. Das c-Jun NH2-terminal kinase-mediated redox-dependent degradation of IkappaB: role of thioredoxin in NF-kappaB activation J Biol Chem 276 2001 4662 4670
51. T. Hayashi, Y. Ueno, and T. Okamoto Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin J Biol Chem 268 1993 11380 11388 (Pubitemid 23162336)
52. X. Chen, K. Kandasamy, and R.K. Srivastava Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling Cancer Res 63 2003 1059 1066 (Pubitemid 36278439)
53. L. Zhang, and B. Fang Mechanisms of resistance to TRAIL-induced apoptosis in cancer Cancer Gene Ther 12 2005 228 237 (Pubitemid 40315182)